| Product Code: ETC11581509 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Chemotherapy-Induced Nauvomiting Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, 2021 & 2031F |
3.3 China Chemotherapy-Induced Nauvomiting Market - Industry Life Cycle |
3.4 China Chemotherapy-Induced Nauvomiting Market - Porter's Five Forces |
3.5 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Chemotherapy-Induced Nauvomiting Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in China |
4.2.2 Growth in chemotherapy utilization rates |
4.2.3 Advancements in chemotherapy-induced nausea and vomiting (CINV) treatment options |
4.2.4 Rising awareness about the importance of managing CINV effectively |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for CINV treatment drugs in China |
4.3.2 High cost associated with CINV medications |
4.3.3 Adverse effects of chemotherapy on patient well-being |
5 China Chemotherapy-Induced Nauvomiting Market Trends |
6 China Chemotherapy-Induced Nauvomiting Market, By Types |
6.1 China Chemotherapy-Induced Nauvomiting Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Serotonin (5-HT3) Receptor Antagonists, 2021 - 2031F |
6.1.4 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Neurokinin-1 (NK-1) Receptor Antagonists, 2021 - 2031F |
6.1.5 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Cannabinoids, 2021 - 2031F |
6.1.6 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Non-Pharmacological Therapies, 2021 - 2031F |
6.2 China Chemotherapy-Induced Nauvomiting Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Neurotransmitter Blockade, 2021 - 2031F |
6.2.3 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By CNS Pathway Modulation, 2021 - 2031F |
6.2.4 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Endocannabinoid System Modulation, 2021 - 2031F |
6.2.5 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Acupressure & Aromatherapy, 2021 - 2031F |
6.3 China Chemotherapy-Induced Nauvomiting Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Oncology Patients, 2021 - 2031F |
6.3.3 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.3.4 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Cancer Survivors, 2021 - 2031F |
6.3.5 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Homecare & Alternative Medicine Centers, 2021 - 2031F |
6.4 China Chemotherapy-Induced Nauvomiting Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Delayed CINV Management, 2021 - 2031F |
6.4.3 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Prevention of Nausea and Vomiting, 2021 - 2031F |
6.4.4 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Symptom Relief, 2021 - 2031F |
6.4.5 China Chemotherapy-Induced Nauvomiting Market Revenues & Volume, By Complementary CINV Management, 2021 - 2031F |
7 China Chemotherapy-Induced Nauvomiting Market Import-Export Trade Statistics |
7.1 China Chemotherapy-Induced Nauvomiting Market Export to Major Countries |
7.2 China Chemotherapy-Induced Nauvomiting Market Imports from Major Countries |
8 China Chemotherapy-Induced Nauvomiting Market Key Performance Indicators |
8.1 Patient-reported outcomes related to CINV management |
8.2 Healthcare provider adoption rates of new CINV treatment guidelines |
8.3 Rate of incorporation of alternative therapies for CINV management |
8.4 Number of clinical trials focused on developing innovative CINV treatments |
9 China Chemotherapy-Induced Nauvomiting Market - Opportunity Assessment |
9.1 China Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 China Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 China Chemotherapy-Induced Nauvomiting Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Chemotherapy-Induced Nauvomiting Market - Competitive Landscape |
10.1 China Chemotherapy-Induced Nauvomiting Market Revenue Share, By Companies, 2024 |
10.2 China Chemotherapy-Induced Nauvomiting Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here